BIOMAT Database Logo BIOMAT Database Logo

Role of autoantibodies and blood-brain barrier leakage in cognitive impairment in systemic lupus erythematosus. 2022

John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Division of Rheumatology, Department of Medicine and Pathology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada john.hanly@nshealth.ca.

Cognitive impairment is common in patients with SLE but the cause is unknown. The current cross-sectional study examined the association between select SLE-related autoantibodies, other serological biomarkers and extensive blood-brain barrier (BBB) leakage in patients with SLE with and without cognitive impairment. In addition, we determined whether the relationship between SLE autoantibodies, other biomarkers and cognitive impairment differed depending on the presence or absence of concurrent extensive BBB leakage. Consecutive patients with SLE, recruited from a single academic medical centre, underwent formal neuropsychological testing for assessment of cognitive function. On the same day, BBB permeability was determined using dynamic contrast-enhanced MRI scanning. SLE autoantibodies and other serological biomarkers were measured. Regression modelling was used to determine the association between cognitive impairment, extensive BBB leakage and autoantibodies/biomarkers. There were 102 patients with SLE; 90% were female and 88% were Caucasian, with a mean±SD age of 48.9±13.8 years. The mean±SD SLE disease duration was 14.8±11.0 years. Impairment in one or more cognitive tests was present in 47 of 101 (47%) patients and included deficits in information processing speed (9%), attention span (21%), new learning (8%), delayed recall (15%) and executive abilities (21%). Extensive BBB leakage was present in 20 of 79 (25%) patients and was associated with cognitive impairment (15 of 20 (75%) vs 24 of 59 (41%); p=0.01) and shorter disease duration (median (IQR): 7 (8-24 years) vs 15 (2-16 years); p=0.02). No serological parameters were associated with extensive BBB leakage and there was no statistically significant association between cognitive impairment and circulating autoantibodies even after adjusting for BBB leakage. Extensive BBB leakage alone was associated with cognitive impairment. These findings suggest that BBB leakage is an important contributor to cognitive impairment, regardless of circulating SLE-related autoantibodies.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment.
December 2020, Annals of the rheumatic diseases,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Brain reactive autoantibodies and cognitive impairment in systemic lupus erythematosus.
June 1994, Lupus,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Cognitive impairment and autoantibodies in systemic lupus erythematosus.
April 1993, British journal of rheumatology,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Correspondence on 'Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment'.
May 2023, Annals of the rheumatic diseases,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
January 2018, Clinical and experimental rheumatology,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
The blood-brain barrier in systemic lupus erythematosus.
January 2003, Lupus,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Response to: 'Correspondence on 'Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment'' by Pamuk and Hasni.
May 2023, Annals of the rheumatic diseases,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
[Cognitive impairment in systemic lupus erythematosus].
January 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus.
August 2019, AJNR. American journal of neuroradiology,
John G Hanly, and Alexandra Legge, and Lyna Kamintsky, and Alon Friedman, and Javeria A Hashmi, and Steven D Beyea, and John Fisk, and Antonina Omisade, and Cynthia Calkin, and Tim Bardouille, and Chris Bowen, and Kara Matheson, and Marvin J Fritzler
Prevalence of cognitive impairment in systemic lupus erythematosus.
June 1986, The Journal of nervous and mental disease,
Copied contents to your clipboard!